SE503436C2 - Pyroglutamidderivat - Google Patents

Pyroglutamidderivat

Info

Publication number
SE503436C2
SE503436C2 SE8700203A SE8700203A SE503436C2 SE 503436 C2 SE503436 C2 SE 503436C2 SE 8700203 A SE8700203 A SE 8700203A SE 8700203 A SE8700203 A SE 8700203A SE 503436 C2 SE503436 C2 SE 503436C2
Authority
SE
Sweden
Prior art keywords
pyroglutamidderivat
humans
animals
administration
useful
Prior art date
Application number
SE8700203A
Other languages
English (en)
Swedish (sv)
Other versions
SE503436C3 (sv
SE8700203L (sv
SE8700203D0 (sv
Inventor
Kiyoshi Kimura
Shoichi Chokai
Toshio Tomita
Masahiro Kise
Kenichi Nakamura
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of SE8700203D0 publication Critical patent/SE8700203D0/xx
Publication of SE503436C3 publication Critical patent/SE503436C3/sv
Publication of SE8700203L publication Critical patent/SE8700203L/xx
Publication of SE503436C2 publication Critical patent/SE503436C2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
SE8700203A 1986-01-21 1987-01-20 Pyroglutamidderivat SE503436C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1135986 1986-01-21
JP1136086 1986-01-21
JP17516886 1986-07-24

Publications (4)

Publication Number Publication Date
SE8700203D0 SE8700203D0 (sv) 1987-01-20
SE503436C3 SE503436C3 (sv) 1987-07-22
SE8700203L SE8700203L (sv) 1987-07-22
SE503436C2 true SE503436C2 (sv) 1996-06-17

Family

ID=27279384

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8700203A SE503436C2 (sv) 1986-01-21 1987-01-20 Pyroglutamidderivat

Country Status (11)

Country Link
US (1) US5102882A (hu)
BE (1) BE1003248A5 (hu)
CA (1) CA1323874C (hu)
CH (1) CH675418A5 (hu)
DE (2) DE3701494A1 (hu)
ES (1) ES2002083A6 (hu)
FR (2) FR2597100A1 (hu)
GB (1) GB2185483B (hu)
IT (1) IT1205715B (hu)
NL (1) NL192304C (hu)
SE (1) SE503436C2 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0367393A3 (en) * 1988-10-31 1991-03-27 Takeda Chemical Industries, Ltd. New heterocyclic compounds, production and use thereof
IT1244507B (it) * 1991-04-11 1994-07-15 Sigma Tau Ind Farmaceuti Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
FR2680508B1 (fr) * 1991-08-20 1995-03-03 Adir Nouveaux composes amidiques des 1-(alcoxybenzyl)piperazines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
EP0711554A4 (en) * 1993-07-28 1997-07-23 Nippon Shinyaku Co Ltd ANTIDEPRESSANT
GB9420784D0 (en) * 1994-10-14 1994-11-30 Glaxo Group Ltd Medicaments
EP0869793A4 (en) * 1995-11-13 1999-02-03 Smithkline Beecham Corp HEMOREGULATORY COMPOUNDS
CZ20022720A3 (cs) * 2000-02-11 2002-11-13 Vertex Pharmaceuticals Incorporated Deriváty piperazinu a piperidinu pro pouľití při léčení a prevenci poąkozených neuronů
US20040180880A1 (en) * 2002-10-03 2004-09-16 Lauffer David J. Piperazine and piperidine derivatives
MY153432A (en) 2007-01-12 2015-02-13 Novartis Ag Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
DE102008003826B4 (de) * 2008-01-10 2010-07-22 Clariant International Limited Verwendung von Salzen als Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität und diese Salze
DE102008003828B3 (de) 2008-01-10 2009-09-03 Clariant International Limited Verwendung von Salzen als Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität und diese Salze
KR101476937B1 (ko) 2010-08-23 2014-12-24 노파르티스 아게 Nep 억제제의 제조를 위한 중간체의 제조 방법
WO2016205348A1 (en) 2015-06-15 2016-12-22 The Children's Hospital Of Philadelphia Methods of diagnosing and treating autism
BR112020014675A2 (pt) * 2018-01-18 2021-02-17 The Children's Hospital Of Philadelphia formas cristalinas de fasoracetam
EP3740204A4 (en) * 2018-01-18 2021-10-06 The Children's Hospital Of Philadelphia SOLID STATE FORMS OF FASORACETAM
GB202300833D0 (en) * 2023-01-19 2023-03-08 Nrg Therapeutics Ltd Novel compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3051722A (en) * 1960-10-21 1962-08-28 Lakeside Lab Inc 5-pyrrolidone-2-carboxamides
JPS5015793B2 (hu) * 1972-06-07 1975-06-07
JPS518266A (en) * 1974-07-10 1976-01-23 Sakai Chemical Industry Co Piroridonjudotaino seizohoho
GB1492640A (en) * 1975-07-08 1977-11-23 Ucb Sa L-pyroglutamyl-l-prolinamide
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
HU180925B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem
JPS56147766A (en) * 1980-04-17 1981-11-16 Sakai Chem Ind Co Ltd Preparation of lactam
DE3031118A1 (de) * 1980-08-18 1982-04-01 Meditest Institut für medizinisch-pharmazeutische Untersuchungen GmbH & Co KG, 7958 Laupheim N,n'-bis(5-oxo-1-methyl-pyrrolidin-2-yl-essigsaeure)-hydrazid, verfahren zu dessen herstellung und seine verwendung als arzneimittel
HU184481B (en) * 1981-10-02 1984-08-28 Richter Gedeon Vegyeszet Process for producing tripeptides for diminishing appetite
GB2130590B (en) * 1982-11-10 1986-01-08 Erba Farmitalia Peptides
US4483991A (en) * 1983-01-17 1984-11-20 American Home Products Corporation Hypotensive agents
US4525476A (en) * 1983-05-26 1985-06-25 Warner-Lambert Company N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators
IT1172391B (it) * 1983-12-23 1987-06-18 Polifarma Spa Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
BE1003248A5 (fr) 1992-02-11
ES2002083A6 (es) 1988-07-01
DE3701494A1 (de) 1987-07-23
CA1323874C (en) 1993-11-02
IT8747545A0 (it) 1987-01-20
FR2597100A1 (fr) 1987-10-16
GB2185483A (en) 1987-07-22
SE8700203L (sv) 1987-07-22
NL192304B (nl) 1997-01-06
US5102882A (en) 1992-04-07
NL8700119A (nl) 1987-08-17
NL192304C (nl) 1997-05-07
FR2597100B1 (hu) 1994-08-19
CH675418A5 (hu) 1990-09-28
DE3744947C2 (hu) 1992-07-16
IT1205715B (it) 1989-03-31
FR2613366A1 (fr) 1988-10-07
SE8700203D0 (sv) 1987-01-20
GB8701245D0 (en) 1987-02-25
GB2185483B (en) 1990-10-24
FR2613366B1 (hu) 1994-08-19

Similar Documents

Publication Publication Date Title
SE8700203L (sv) Pyroglutamidderivat
DE3853922D1 (de) Aminosäurederivate als Amphotere.
FI884409A0 (fi) Tuholaistorjunta-aineina käyttökelpoiset 2-anilino-pyrimidiinijohdannaiset
DK203187D0 (da) Human g-csf proteinekspression
SE8702109D0 (sv) Tetrahydronaphthalin- und indanderivate
SE8600998D0 (sv) Parenterala fenytoinpreparat
BR9103506A (pt) Novos usos de l-deprenil e composicoes para ele
DK90089A (da) Hudbehandlingspraeparat
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
IT8648200A0 (it) Derivati benzimidazolici utili come agenti antiulcera
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ES2066305T3 (es) Composicion nutricional y procedimiento de obtencion.
PT87554A (pt) Didinfecting and sterilizing composition
ES2058343T3 (es) Piridinas disubstituidas.
ES2041845T3 (es) Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos.
FI850304A0 (fi) Indolofenathridiner.
ES525297A0 (es) Procedimiento para la obtencion de derivados de terc.-butanol sustituidos
DK335587D0 (da) Vaeskefremmende veterinaerpraeparater
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
GR3005231T3 (hu)
IT8705102A0 (it) Derivati di prolina.
IT1216830B (it) Derivati 1,4-diidropiridinici quali agenti emoreologici
IT8603514A0 (it) Striglia medicata in particolareper animali domestici
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.
FR2604704B1 (fr) Derives de 4-phenylthiazole, procede de preparation et utilisation en therapeutique

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8700203-6

Format of ref document f/p: F